Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis
ConclusionSerum CA 15-3 correlates with PFT during 6 months of immunosuppressive therapy in HP. Interestingly, early CA 15-3 changes could predict future PFT. Furthermore, a decrease in CA 15-3 is related to longer survival. Therefore, serum CA 15-3 is a promising biomarker for implementation in HP care.
Source: Lung - Category: Respiratory Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Interstitial Lung Disease | Prednisone | Respiratory Medicine